CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 10-K Report Annual Report
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 4 Shares withheld for taxes CHIEF LEGAL OFFICER & gave up 593 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT & CHIEF OPERATING gave up 4,778 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,479 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 1,381 shares (to pay taxes)
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Other acquisition CHIEF LEGAL OFFICER & acquired 179 shares (other)
- 4 Shares withheld for taxes PRESIDENT & CHIEF OPERATING gave up 2,917 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,269 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT & CHIEF OPERATING gave up 1,984 shares (to pay taxes)
- 8-K Event Material agreement
- 8-K/A Event Results of operations
Page 15 of 115 · 2,300 filings